1) Medical Countermeasures Initiative (MCMI)
Abstract
Medical Countermeasures Initiative (MCMI): Coordinate inter-related advanced development and flexible manufacturing capabilities, based on partnerships between the government and industry, providing a dedicated, cost-effective, reliable, and sustainable MCM process that meets the warfighter and national security needs. Specifically, the MCMI will provide the capability for the advanced development and flexible manufacturing of biological MCM (to include TMT developed MCMs) to address CBRN threats, including novel and previously unrecognized, naturally-occurring emerging infectious diseases. MCMI efforts within S&T are concentrated in two areas: 1) advancement of regulatory science, and 2) advancements in flexible manufacturing technologies for MCMs.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2013
- Source ID
- e8ac0f9b49fa7df46d416a3ab565eaf8